|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/7088 | |
| A61P 3/06 |
| (11) | Number of the document | 3357497 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18155337.1 |
| Date of filing the European patent application | 2012-04-27 | |
| (97) | Date of publication of the European application | 2018-08-08 |
| (45) | Date of publication and mention of the grant of the patent | 2020-10-14 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 201161479817 P | 2011-04-27 | US | |
| 201261595009 P | 2012-02-03 | US |
| (72) |
MULLICK, Adam, US
CROOKE, Rosanne, M., US
GRAHAM, Mark, J., US
DOBIE, Kenneth, W., US
BELL, Thomas, A., US
LEE, Richard, US
|
| (73) |
Ionis Pharmaceuticals, Inc.,
2855 Gazelle Court, Carlsbad, CA 92010,
US
|
| (54) | MODULATION OF APOLIPOPROTEIN CIII (APOCIII) EXPRESSION |
| MODULATION OF APOLIPOPROTEIN CIII (APOCIII) EXPRESSION |